1. | Blum J, Trademarks in the pharmaceutical sector: the dynamic between brands, proprietary names and labelling regulations, in: Alemanno A. (ed.). The New Intellectual Property of Health Beyond Plain Packaging, Cheltenham 2016. |
2. | Fry, J. N., Family branding and consumer brand choice, Journal of Marketing Research 1986, Vol. 4, No. 3, DOI:10.2307/3149455, access on: 01.02.2020. |
3. | Ignatowicz, Z., Reklama produktów leczniczych (Advertisement of Medicinal Products), in: Olszewski W.L. (ed.) Prawo farmaceutyczne. Komentarz (The Pharmaceutical Law. Commentary), Warsaw 2016. |
4. | Kondrat, M. et al. Prawo suplementów diety (The Dietary Supplements Law), Warsaw 2012, |
5. | Ministry of Health, Polityka Lekowa Państwa 2018–2022 (State Drug Policy 2018–2022), 2018. https://www.gov.pl/web/zdrowie, access on: 01.02.2020. |
6. | Makowska, M., Jasiński Ł., A discussion of the unresolved 2016/17 plans for regulating the Polish dietary supplements market, Health Policy 2019, Vol. 123, No. 6, DOI: 10.1016/j.healthpol.2019.04.001, access on: 1.02.2020. |
7. | Mokrysz-Olszyńska, A., Advertising of dietary supplements as a challenge for legislator and regulator, Annals of the Administration and Law 2016, V. 16/2, 233-250. |
8. | Mruk, H. et al., Marketing strategiczny na rynku farmaceutycznym (Strategic Marketing in the Pharmaceutical Market), Warsaw 2014. |
9. | Pierewoj, J., Suplement diety a bezpieczeństwo konsumentów – wybrane aspekty prawa polskiego oraz prawa Unii Europejskiej (Dietary Supplement vs Consumers’ Safety – Selected Aspects of the Polish Law and the European Union Law), in: Porzeżyński, M., Borcuch A. (eds.), Bezpieczeństwo w erze społeczeństwa informacyjnego. Wyzwania w sferach kultury, marketingu i gospodarki (Safety in the Era of Information Society. Challenges for Culture, Marketing and Economy), Kielce 2019. |
10. | Roszak, M., Granice stosowania praktyki umbrella brandingu (znaków parasolowych) na rynku farmaceutycznym (Restrictions in Applying the Umbrella Branding in the Pharmaceutical Market), in: Kępiński M. (ed.), Rynek farmaceutyczny, a prawo własności intelektualnej (The Pharmaceutical Market vs the Intellectual Property Right), Warsaw 2013. |
11. | Supreme Audit Office, Dopuszczenie do obrotu suplementów diety (Admission of Dietary Supplements to Trading), 2017. https://www.nik.gov.pl/, access on: 01.02.2020. |
12. | Szczęsny, R., Reklama farmaceutyczna i pokrewna (Pharmaceutical and Related Advertisement), Warsaw 2010. |
13. | The Ministry of Health, The Report of the Team for Regulating Advertisement of Medicines, Dietary Supplements and Other Foodstuff and Medicinal Products, 2016, https://www.gov.pl/web/zdrowie/, access on: 20.02.2020. |